Cargando…

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortoletto, Riccardo, Colizzi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407973/
https://www.ncbi.nlm.nih.gov/pubmed/36011210
http://dx.doi.org/10.3390/healthcare10081553
_version_ 1784774493916364800
author Bortoletto, Riccardo
Colizzi, Marco
author_facet Bortoletto, Riccardo
Colizzi, Marco
author_sort Bortoletto, Riccardo
collection PubMed
description Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive epigenetic effects that can be intergenerationally inherited in brain areas which play a critical role in schizophrenia pathophysiology. Additionally, because of such cannabinoid-induced epigenetic effects, autism candidate genes present with bivalent chromatin markings which make them more vulnerable to subsequent disruption, possibly leading to psychosis onset later in life. Thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. However, such evidence has not received the attention it deserves.
format Online
Article
Text
id pubmed-9407973
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94079732022-08-26 Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis Bortoletto, Riccardo Colizzi, Marco Healthcare (Basel) Viewpoint Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. More specifically, cannabis exposure among autism spectrum individuals seems to exert disruptive epigenetic effects that can be intergenerationally inherited in brain areas which play a critical role in schizophrenia pathophysiology. Additionally, because of such cannabinoid-induced epigenetic effects, autism candidate genes present with bivalent chromatin markings which make them more vulnerable to subsequent disruption, possibly leading to psychosis onset later in life. Thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. However, such evidence has not received the attention it deserves. MDPI 2022-08-16 /pmc/articles/PMC9407973/ /pubmed/36011210 http://dx.doi.org/10.3390/healthcare10081553 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Viewpoint
Bortoletto, Riccardo
Colizzi, Marco
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title_full Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title_fullStr Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title_full_unstemmed Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title_short Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
title_sort cannabis use in autism: reasons for concern about risk for psychosis
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407973/
https://www.ncbi.nlm.nih.gov/pubmed/36011210
http://dx.doi.org/10.3390/healthcare10081553
work_keys_str_mv AT bortolettoriccardo cannabisuseinautismreasonsforconcernaboutriskforpsychosis
AT colizzimarco cannabisuseinautismreasonsforconcernaboutriskforpsychosis